September 22, 2017 6:41 AM ET


Company Overview of A2A Pharmaceuticals, Inc.

Key Executives for A2A Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Edward Painter MBA3 RelationshipsCo-Founder and Director--
Sridhar Vempati MBA, Ph.D.3 RelationshipsCo-Founder and Director--
Matthew Welsch Ph.D.3 RelationshipsCo-Founder and Director--

A2A Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sotirios Stergiopoulos M.D., MBEE 3 RelationshipsA2A Pharmaceuticals, Inc.--
Edward Painter MBA 3 RelationshipsHumanigen, Inc.--
Matthew Welsch Ph.D. 3 RelationshipsA2A Pharmaceuticals, Inc.--
Sridhar Vempati MBA, Ph.D. 3 RelationshipsA2A Pharmaceuticals, Inc.--
View All Board Members

A2A Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
A2A Pharmaceuticals, Inc. CEO Compensation
Industry Average


American BriVision (Holding) Corporation Announces Management Changes
September 20, 2017 7:01 PM ET
bluebird bio, Inc. Announces Board Changes
September 20, 2017 12:00 PM ET
Trovagene, Inc. Appoints Athena Countouriotis to the Board of Directors
September 20, 2017 12:00 PM ET
Arvinas LLC Appoints John Houston as President and Chief Executive Officer
September 20, 2017 12:00 PM ET
VALBIOTIS Appoints Jean Zetlaoui on Valbiotis to Supervisory Board
September 20, 2017 5:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact A2A Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at